Shubham co-leads McKinsey’s work on helping leading institutions navigate and reorient to the new realities of the shifting geopolitical landscape. Prior to that he was the global leader of McKinsey’s Social, Healthcare and Public Entities (SHaPE) Practice from 2020–24, global leader of McKinsey’s Healthcare Practice from 2016–20, and leader of McKinsey’s Americas Healthcare Practice from 2012–16. He also led McKinsey’s COVID-19 response efforts globally from 2020–22. He is currently a member of McKinsey’s Shareholders Council (our global governance board).
Shubham counsels CEOs and senior executives as well as boards and private investors across healthcare to help them innovate and transform their institutions. He helps top management teams architect their strategy based on a very deep view of the future of healthcare, develop their change agenda to translate vision to reality, and design and execute transformation efforts.
Shubham leads McKinsey’s thinking and research on the future of healthcare in the wake of rapid advancements in technology, advanced analytics, and medical technologies; emergence of new treatments; regulatory change; the growing influence of the healthcare consumer; and risk disaggregation and reallocation across the healthcare system. He has deeply studied the shifts in overall spend as well as profit pools within the healthcare industry as these structural shifts play out. His expertise has been key in defining the structural and performance implications of this transformation for payers, providers, pharmacy value chain players, and healthcare services and technology organizations.
Published work
“Navigating tariffs with a geopolitical nerve center,” McKinsey & Company, April 2025
“Restricted: How export controls are reshaping markets,” McKinsey & Company, April 2025
“Navigating the new geopolitical uncertainty,” McKinsey & Company, January 2025
“What to expect in US healthcare in 2025 and beyond,” McKinsey & Company, January 2025
“Tariffs on the move? A guide for CEOs for 2025 and beyond,” McKinsey & Company, December 2024
“How the healthcare industry can weather ongoing challenges,” McKinsey & Company, December 2024
“A proactive approach to navigating geopolitics is essential to thrive,” McKinsey & Company, November 2024
“The AI opportunity: How payers can capture it now,” McKinsey & Company, June 2024
“Value creation through business model innovation in US healthcare,” McKinsey & Company, April 2024
“What to expect in US healthcare in 2024 and beyond,” McKinsey & Company, January 2024
“Healthcare’s next chapter: What’s ahead for the US healthcare industry,” McKinsey & Company, December 2023
“US government productivity: The roles government plays,” McKinsey & Company, October 2023
“Leadership rundown: How US healthcare leaders are scaling innovation and transformation,” McKinsey & Company, October 2023
“US government productivity: A more than $2,000 per resident opportunity,” McKinsey & Company, September 2023
“One billion days lost: How COVID-19 is hurting the US workforce,” McKinsey & Company, January 2023
“What to expect in US healthcare in 2023 and beyond,” McKinsey & Company, January 2023
“US health systems: Diversify to thrive,” McKinsey & Company, November 2022
“The gathering storm: The threat to employee healthcare benefits,” McKinsey & Company, October 2022
“The gathering storm: An opportunity to reorder the healthcare industry,” McKinsey & Company, September 2022
“The gathering storm: The affordability challenge of endemic COVID-19,” McKinsey & Company, September 2022
“The gathering storm: The transformative impact of inflation on the healthcare sector,” McKinsey & Company, September 2022
“The gathering storm: The uncertain future of US healthcare,” McKinsey & Company, September 2022
“The gathering storm in US healthcare: How leaders can respond and thrive,” McKinsey & Company, September 2022
“When will the COVID-19 pandemic end?,” McKinsey & Company, July 2022
“The future of US healthcare: What’s next for the industry post-COVID-19,” McKinsey & Company, July 2022
“The next frontier of care delivery in healthcare,” McKinsey & Company, March 2022
“When will the COVID-19 pandemic end?,” McKinsey & Company, March 2022
“Consumer prices are rising fast, and healthcare isn’t far behind,” McKinsey & Company, February 2022
“New variant, new challenges: How are we coping with Omicron?,” McKinsey & Company, February 2022
“When will the COVID-19 pandemic end?,” McKinsey & Company, December 2021
“Pandemic to endemic: How the world can learn to live with COVID-19,” McKinsey & Company, October 2021
“Innovating employee health: Time to break the mold?,” McKinsey & Company, September 2021
“When will the COVID-19 pandemic end?,” McKinsey & Company, August 2021
“A light at the end of the tunnel: US COVID-19 vaccine administration,” McKinsey & Company, April 2021
“Leap to the future of healthcare: Reinvent through business building,” McKinsey & Company, April 2021
“The risks and challenges of the global COVID-19-vaccine rollout,” McKinsey & Company, January 2021
“The next normal arrives: Trends that will define 2021—and beyond,” McKinsey & Company, January 2021
“What now? Decisive actions to emerge stronger in the next normal,” McKinsey & Company, September 2020
“The great acceleration in healthcare: Six trends to heed,” McKinsey & Company, September 2020
“An optimistic scenario for the US response to COVID-19,” McKinsey & Company, September 2020
“COVID-19: Saving thousands of lives and trillions in livelihoods,” McKinsey & Company, August 2020
“‘And now win the peace’: Ten lessons from history for the next normal,” McKinsey & Company, July 2020
“Ten innovations that can improve global health,” McKinsey & Company, July 2020
“How prioritizing health could help rebuild economies,” McKinsey & Company, July 2020
“Reopening safely: Sample practices from essential businesses,” McKinsey & Company, May 2020
“From thinking about the next normal to making it work: What to stop, start, and accelerate,” McKinsey & Company, May 2020
“COVID-19: Strategies for getting ahead of the pandemic crisis,” McKinsey & Company, April 2020
“The future is not what it used to be: Thoughts on the shape of the next normal,” McKinsey & Company, April 2020
“Critical care capacity: The number to watch during the battle of COVID-19,” McKinsey & Company, March 2020
“Beyond coronavirus: The path to the next normal,” McKinsey & Company, March 2020
Future of Healthcare
“The future of healthcare: Value creation through next-generation business models,” McKinsey & Company, January 2021
“Fit for the future: The common challenges facing healthcare systems—and how to meet them,” McKinsey & Company, October 2019
“Recession and resilience: Preparing healthcare leaders for the next economic downturn,” McKinsey & Company, July 2019
“The era of exponential improvement in healthcare?,” McKinsey & Company, May 2019
“The future of healthcare: Finding the opportunities that lie beneath the uncertainty,” McKinsey & Company, January 2018
“Why the evolving healthcare services and technology market matters,” McKinsey & Company, May 2018
“Planning for the future of healthcare – Benjamin Breier, President and CEO, Kindred Healthcare,” McKinsey & Company, December 2017
Productivity and Growth
“The productivity imperative for healthcare delivery in the United States,” McKinsey & Company, February 2019
“Trends disrupting pharmacy value pools and potential implications for the value chain,” McKinsey & Company, February 2018
“Where to compete in today’s healthcare market,” McKinsey & Company, May 2017
“Value-based care: is it sustainable?” McKinsey & Company, May 2017
“The growth opportunity for private health insurance companies,” McKinsey & Company, January 2017
“Payors in Care Delivery: When Does Vertical Integration Make Sense?” Health Affairs, February 2014
Past Experience
Unilever
Various executive positions, including plant and engineering management
Education
Carnegie Mellon University
MBA
Indian Institute of Technology, Bombay
BSc, mechanical engineering